Skip to main content
AMRZ logo

AMRZ · Amrize Ltd

Track AMRZ — free
$37.25 -0.14 (-0.37%) At close · Oct 1
Market Cap
$20.81B
Shares
546.93M
Volume · Oct 1 4.99M Avg daily vol (3M) 3.71M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$37.25 Open$37.40 Day$36.55–37.57 52W close$37.23–65.86 Avg vol 30d4.2M Short int9.7M · 1.8% float · 2.0d Short vol56% Last earningsOct 30, 2026 DataJun 2025–Oct 2026 Filing10-Q · Aug 10

Up next

Next earnings call
Oct 30, 2026 Scheduled · in 4 wks
filed Aug 10, 2026
call held Apr 30, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$12.18B
Trailing 12 months
Net income (TTM)
$1.24B
Trailing 12 months
Revenue growth YoY
+8.6%
Year over year
Operating margin
15.5%
Trailing 12 months
P / E (TTM)
16.8
Trailing earnings · reciprocal yield 6.0%
FCF yield
6.3%
TTM · current market cap
Return on invested capital
8.5%
Trailing 12 months
Net cash
−$4.54B
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.1%
Year over year · more shares
Price change (1Y)
-23.0%
Trailing year
Short interest
1.8%
Latest settlement · 2.0 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Bullish Fundamentals Fair Quant / Vol High
Market backdrop VIX 16.4 · calm Equity put/call 0.57
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −29%
below
Price vs 50-day avg −15%
below
RSI (14) 31
neutral
MACD trend Positive
52-week position 0%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −13%
trailing
6-month return −36%
trailing
YTD return −31%
this year
Relative strength −48%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $44 › 200d $52 — 200d above 50d
Institutional flow Accumulating
+4% holders QoQ · +75 funds added
Insider flow Accumulating
Net +$2.6M over 90 days · 0% sells
Short interest Rising
1.78% of float · ▲ +6.0% MoM · 2.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
467 holders — near 1-yr high, broad support
Squeeze score 43
elevated · 0–100
Fundamentals
Fair
Revenue growth +1%
Y/Y
Gross margin 26%
contracting
EPS growth −7%
Y/Y
Free cash flow $1.4B
Valuation P/E 17.1
below peers
Balance sheet $3.3B
net debt
Quant / Vol
risk profile
High
Volatility 37%
annualized · 1-yr
Max drawdown −43%
past year
ATR 3.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the 8-K filed Aug 6, 2026
FY 2026
Revenues Initiated $12.5B – $12.7B
prior FY $11.82B midpoint +6.6% Y/Y
Adjusted EBITDA Initiated $3.1B – $3.2B
Capex Initiated $900M
2026
Capital Expenditures $900M
Interest Expense, Net $340M
Adjusted Effective Tax Rate 23% – 25%
Corporate Costs $200M
Prior guidance period ended · from the Earnings Call filed Apr 30, 2026
Aggregates price increase · Q2 5%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−29% Bearish
Price vs 50-day avg
−15% Bearish
RSI (14)
31 Neutral
MACD trend
Positive Bullish
52-week position
0% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross) No cross
50d $44 › 200d $52 — 200d above 50d
Institutional flow Accumulating
+4% holders QoQ · +75 funds added
Insider flow Accumulating
Net +$2.6M over 90 days · 0% sells
Short interest Rising
1.78% of float · ▲ +6.0% MoM · 2.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
467 holders — near 1-yr high, broad support
Price context
position in its 52-week range
Range low $37 Now $37 · 0% Range high $66
vs 200-day avg -29% vs 50-day avg -15%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted EBITDA non-GAAP $986M the three months ended June 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP EBITDA 968M
+10M Acquisition and integration-related costs
-5M Litigation-related (settlements) costs
+2M Loss on impairments
+5M Restructuring and other costs
+6M Spin-off and separation-related costs
+1M Other non-operating expense (income), net
-1M Income from equity method investments
= Adjusted EBITDA 986M
Adjusted EBITDA Margin non-GAAP 28.2% the three months ended June 30, 2026 filing —
Aggregates - tons sold 34.3M the three months ended June 30, 2026 filing —
Building Envelope Segment Adjusted EBITDA non-GAAP $237M the three months ended June 30, 2026 filing —
Building Envelope segment share of revenues 30% the three months ended June 30, 2026 filing —
Building Materials Segment Adjusted EBITDA non-GAAP $793M the three months ended June 30, 2026 filing —
Cement - tons sold 6.3M the three months ended June 30, 2026 filing —
EBITDA non-GAAP $968M For the three months ended June 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP Net income 476M
+257M Depreciation, depletion, accretion and amortization
+89M Interest expense, net
+146M Income tax expense
= EBITDA 968M
EBITDA Margin non-GAAP 27.7% For the three months ended June 30, 2026 filing —
Total capital expenditures $244M the three months ended June 30, 2026 filing —
Total lease expense $100M the three months ended June 30, 2026 filing —
Total Segment Adjusted EBITDA non-GAAP $1.03B the three months ended June 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP Adjusted EBITDA 986M
+44M Unallocated corporate costs
= Total Segment Adjusted EBITDA 1.03B
Unallocated corporate costs non-GAAP -$44M the three months ended June 30, 2026 filing —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Building Materials — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
AMRZ
Amrize Ltd
this stock
$20.81B -31.1% +0.9% 17.1 1.8%
CRH
Crh Public Ltd Co
$55.52B -34.5% +5.3% 14.8 1.8%
VMC
Vulcan Materials CO
$31.79B -14.5% +6.4% 29.2 4.3%
MLM
Martin Marietta Materials Inc
$29.09B -23.0% +8.6% 11.9 4.8%
JHX
James Hardie Industries plc
$15.15B +21.4% +24.7% — 2.6%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
467
% held
47.6%
Net QoQ
+18.2M sh
Top holder
VANGUARD CAPITAL MANAGEME…
Held Float
View
Held by Funds
Fund positions
80
View
Short & Settlement
Short Interest Rising
Shares short
9.7M
Days to cover
2.0d
Change
+551.5K sh
View
Short Volume
Short vol %
56%
As of
Oct 1, 2026
Short Total
View
Fails to Deliver
FTD shares
312.2K
Value
$12.8M
As of
Sep 10, 2026
View
Off-Exchange
Off-exchange %
36.8%
Week of
Aug 24, 2026
Off-exch Lit
View
Smart Money
Insider Trades Cluster buy
Net (90d)
+$2.6M
Buyers / Sellers
11 / 0
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$11.8B
Net income (FY)
$1.2B
EPS diluted
$2.14
View
Buybacks
Authorized
shares 18.8M
Remaining
shares 15.1M
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Sep 11, 2026
This year
17
View
Earnings & Events
Webcasts Upcoming
Next webcast
Oct 30, 2026
Last webcast
Aug 7, 2026
View
Investor Relations
Upcoming events
1
View

Performance

5D 20D 120D MTD YTD
AMRZ +0.1% -13.3% -35.8% -0.4% -31.1%
SPY -0.4% -0.2% +12.4% +0.2% +12.0%
vs SPY +0.5% -13.2% -48.2% -0.6% -43.2%

Capital returns

Buyback program · as of Jun 30, 2026
Authorized
shares 18.80M
Spent (derived)
shares 3.70M
Remaining
shares 15.10M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 2035989 CUSIP H2927K103 13F (30d) 8 filings 8 filers Visit website Investor relations